MGRAY

MGRAY, based in Suzhou, China, develops high-end medical imaging components, focusing on liquid metal bearing tubes that enhance medical diagnostic capabilities and performance. Founded in 2023, MGRAY operates in the medical technology sector, specializing in innovative imaging components. The company has successfully completed one deal as of April 2026, indicating early growth in business operations. MGRAY specializes in the development and industrialization of high-end medical imaging components, particularly liquid metal bearing tubes.

These proprietary tubes enhance performance and durability in medical imaging devices for hospitals and medical imaging centers, catering to both domestic and international markets. Revenue generation for MGRAY is driven through direct sales to hospitals and medical device manufacturers that require high-quality imaging components. The company operates primarily through B2B arrangements, establishing partnerships to supply its specialized products, which supports ongoing client relationships and repeat orders. MGRAY plans to leverage its most recent funding round in April 2026 to further develop high-power liquid metal bearing tubes and expand its market reach.

The funding will support initiatives to introduce new products aimed at healthcare institutions globally, with a focus on international markets by late 2026.